Pfizer Inc.
PFE
Peringkat dalam Saham
#118
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Harga Saham
$29.47
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$167.94B
Perubahan (1 hari)
-0.27%
Perubahan (1 tahun)
19.34%
Negara
US
Perdagangan Pfizer Inc. (PFE)
Kategori
Healthcare
Jumlah saham beredar untuk Pfizer Inc. (PFE)
Jumlah saham beredar per June 2026: 5.70B
Menurut laporan keuangan terbaru dan harga saham Pfizer Inc., jumlah saham beredar saat ini adalah 5.70B. Pada akhir December 2024, perusahaan memiliki 5.66B saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Pfizer Inc. (PFE) dari 2000 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 5.70B | 0.29% |
| 2025 | 5.68B | 0.33% |
| 2024 | 5.66B | 0.37% |
| 2023 | 5.64B | 0.62% |
| 2022 | 5.61B | 0.12% |
| 2021 | 5.60B | 0.83% |
| 2020 | 5.56B | -0.25% |
| 2019 | 5.57B | -5.16% |
| 2018 | 5.87B | -1.64% |
| 2017 | 5.97B | -1.95% |
| 2016 | 6.09B | -1.41% |
| 2015 | 6.18B | -2.68% |
| 2014 | 6.35B | -6.85% |
| 2013 | 6.81B | -8.45% |
| 2012 | 7.44B | -4.80% |
| 2011 | 7.82B | -2.73% |
| 2010 | 8.04B | 14.69% |
| 2009 | 7.01B | 4.16% |
| 2008 | 6.73B | -2.75% |
| 2007 | 6.92B | -4.49% |
| 2006 | 7.24B | -1.62% |
| 2005 | 7.36B | -2.26% |
| 2004 | 7.53B | 4.41% |
| 2003 | 7.21B | 17.17% |
| 2002 | 6.16B | -1.33% |
| 2001 | 6.24B | 0.47% |
| 2000 | 6.21B | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 892.40M | -84.34% |
US
|
|
| 2.45B | -57.05% |
US
|
|
| 1.77B | -68.92% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | -86.03% |
CH
|
